‘Quality of life in severe asthma measured by SAQ and EQ5D questionnaires as a function of clinically relevant cut off points’ presented at European Respiratory Society (ERS) virtual conference, online. 7-9 September, 2020.
‘The SAQ is a valid quality of life measure in severe asthma: the mini-AQLQ and ACQ both measure symptoms’ presented at European Respiratory Society (ERS) virtual conference, online. 7-9 September, 2020.
‘Is the minimally clinically important difference (MCID) fit for purpose? A planned study using the SAQ’ presented at European Respiratory Society (ERS) virtual conference, online. 7-9 September, 2020.
‘Severe Asthma Questionnaire (SAQ): validation and continuing use’ presented at the British Thoracic Society (BTS) conference, London, England. 4-6 December, 2019.
‘The contribution of extra-pulmonary symptoms to quality of life in severe asthma are important and may be overlooked’ presented at the British Thoracic Society (BTS) conference, London, England. 4-6 December, 2019
‘The Validation of the Severe Asthma Questionnaire (SAQ)’ presented at the American Thoracic Society conference, Dallas, Texas. 17-22 May, 2019.
‘Non-respiratory symptoms are as important as respiratory symptoms in their impact on quality of life in severe asthma’ presented at the American Thoracic Society conference, Dallas, Texas. 17-22 May, 2019.
‘The continuing development and validation of the severe asthma questionnaire (SAQ)’ presented at the Respiratory Effectiveness Group (REG) Summit, Athens, Greece. 28-30 March, 2019.
‘The Validation of the Severe Asthma Questionnaire (SAQ)’ presented at the European Respiratory Society International Congress, Paris, France. 15–19 September, 2018.
‘Quantitative validation of a new quality of life questionnaire for patients with asthma, the Severe Asthma Questionnaire (SAQ)’ presented at the IPCRG World Conference, Porto, Portugal. 31st May – 2nd June, 2018.
‘Developing the Severe Asthma Questionnaire (SAQ) in partnership with patients according to FDA guidelines’ presented at the Respiratory Effectiveness Group (REG) Summit, Amsterdam, Netherlands. 22-24 March, 2018.
‘A new questionnaire to measure quality of life in severe asthma (SAQ): preliminary validation’ presented at the Respiratory Effectiveness Group (REG) Summit, Amsterdam, Netherlands. 22-24 March, 2018.
‘A new questionnaire to measure quality of life in severe asthma (SAQ): preliminary validation’ presented at the British Thoracic Society (BTS) Conference, London, England. 6-8 December 2017.